Olympus America

Press Center

Olympus Introduces UIS2 Optical System


Clinical and Educational Labs Benefit from Higher Performance and Value of New Eco-Friendly Plan Optics

MELVILLE, NY, November 9, 2004 - Olympus, a world leader and recognized innovator in developing new optical technologies, today introduced the new UIS2 Microscope Optical System. The optics allow virtually all Olympus microscope users to enjoy a host of benefits, including aberration-free Plan performance, generally higher numerical apertures and longer working distances, and higher transmission rates from the ultraviolet (UV) light spectrum through the infrared (IR). Importantly for clinical laboratory users, the new high-performance plan optical system is also eco-friendly, with a completely lead-free glass design, and will be offered at virtually the same pricing as achromat optics.

"As optical innovators, we set out to design a system of infinity plan optics that provided superior performance while protecting the environment," said George E. Steares, group vice president of the Olympus Scientific Equipment Group. "Our new glass offers extraordinary performance enhancements while eliminating lead in the manufacturing process. And we have done it without driving up the cost. Many microscope users in clinical labs will now be able to experience the beauty of plan optical performance for the first time."

Olympus UIS2 optics have improved light gathering ability, with higher NAs overall, and many offer improved working distances as well. All of the new optics are designed to fit on current Olympus microscope models without retrofitting.

The UIS2 series includes a full set of Plan C N optics that will replace many achromat objectives for basic brightfield work; and a completely new series of clinical objectives for diagnosticians and educators, among many other optics.

The patent-pending glass designs offer users even clearer, brighter images, with higher signal-to-noise performance and better transmission beyond the visible spectrum for capturing low-light images. In addition to the optics suitability for clinical laboratory work, there are numerous ultra-high-performance Super Plan Apo objectives for life science researchers; UPlan Fluorite N objectives designed for research fluorescence, polarized light microscopy and DIC; a new line of polarized light and phase contrast objectives; and more. Importantly, the new objectives also offer apochromatic focus correction in the near IR spectrum. DIC image contrast is enhanced and images are more even from edge to edge; the unification of back focal plane positions results in fewer DIC prisms overall.

"Olympus is dedicated to environmentally conscious product design," added Steares, "and we continue to enhance optical performance and bring cost benefits to the user - at the same time we develop safer technologies."

For information on Olympus UIS2 optics, contact Olympus America Inc., Scientific Equipment Group, Two Corporate Center Drive, P.O. Box 9058, Melville, NY 11747-9058; website: http://www.olympusamerica.com/microscopes; E-mail: microscopy@olympus.com; Phone: 1-800-446-5967.

About Olympus Scientific Equipment Group
Olympus Scientific Equipment Group provides innovative microscope imaging solutions for researchers, doctors, clinicians and educators. Olympus microscope systems offer unsurpassed optics, superior construction and system versatility to meet the ever-changing needs of microscopists, paving the way for future advances in life science.

About Olympus
Olympus is a precision technology leader, designing and delivering innovative solutions in healthcare and consumer electronics worldwide.

Olympus works collaboratively with its customers and its parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced clinical and research microscopes;
  • Lab automation systems, chemistry-immuno and blood bank analyzers and reagents; and
  • Digital and film cameras, and digital voice recorders.
  • In the U. S. and Canada, Olympus serves healthcare, scientific and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers efficiently, reliably, safely, and easily achieve superior results. Olympus is the leader in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer electronics business spans North and South America. For more information, visit www.olympusamerica.com.